Neueste Veröffentlichungen

• A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer
  Article (Journal), Online Resource
• Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1
  Article (Journal), Online Resource
• Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: a randomized, placebo-controlled, phase 1 trial
  Article (Journal), Online Resource

Alle anzeigen (3)

Co-Autoren

• Beckhove, Philipp
• Büchler, Markus W.
• Friedrich, Tobias
• Grenacher, Lars
• Haefeli, Walter E.

Alle anzeigen (38)

Publikationsjahre

Publikationstypen